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ABSTRACT Targeted molecular dynamics simulations were used to study the conformational transition of inﬂuenza
hemagglutinin (HA) from the native conformation to putative fusogenic or postfusion conformations populated at low pH. Three
pathways for this conformational change were considered. Complete dissociation of the globular domains of HA was observed
in one pathway, whereas smaller rearrangements were observed in the other two. The fusion peptides became exposed and
moved toward the target membrane, although occasional movement toward the viral membrane was also observed. The
effective energy proﬁles along the paths show multiple barriers. The ﬁnal low-pH structures, which are consistent with available
experimental data, are comparable in effective energy to native HA. As a control, the uncleaved precursor HA0 was also forced
along the same pathway. In this case both the ﬁnal energy and the energy barrier were much higher than in the cleaved protein.
This study suggests that 1) as proposed, the native conformation is the global minimum energy conformation for the uncleaved
precursor but a metastable state for cleaved HA; 2) the spring-loaded conformational change is energetically plausible in full-
length HA; and 3) complete globular domain dissociation is not necessary for extension of the coiled coil and fusion peptide
exposure, but the model with complete dissociation has lower energy.
INTRODUCTION
Protein-mediated membrane fusion is a common process in
living organisms (White, 1992). One of the best studied
examples of a membrane fusion machine is the inﬂuenza
virus Hemagglutinin (HA; Wiley and Skehel, 1987; Skehel
and Wiley, 2000; Eckert and Kim, 2001). HA is a glycopro-
tein anchored in the viral lipid membrane by a single
transmembrane domain near its C-terminus. It consists of the
receptor-binding (HA1) and the membrane-anchoring (HA2)
polypeptide chains, which are linked by a disulﬁde bond.
The ﬁrst 20 amino acid residues of the N-terminus of HA2
are highly conserved within the inﬂuenza virus family and
appear to be crucial for virus-cell fusion as shown by site-
directed mutagenesis (Gething et al., 1986; Durell et al.,
1997; Qiao et al., 1999). They are referred to as the fusion
peptide. The virus ﬁrst binds to a sialylated cell surface
receptor, and then enters the cell by endocytosis. The low pH
of the endosome induces a large conformational change
(Skehel et al., 1982), which is thought to trigger fusion bet-
ween the viral and the endosomal membranes. The opti-
mal pH range for membrane fusion by HA is between 5 and
5.5 (Skehel et al., 1982). However, activation of the HA-
mediated membrane fusion has also been reported at neutral
pH either at high temperature or in the presence of a chemical
denaturant (Carr et al., 1997), which suggests that low pH
merely serves to destabilize the native conformation.
The x-ray crystal structure of the ectodomain of HA
(bromelain digested HA, BHA; Wilson et al., 1981) shows
that the native HA is a rodlike homotrimer extending 135 A˚
in length. The N-terminus of the HA1 and the C-terminus of
the HA2 domain are near the viral membrane. The HA2
chains are the major components of the a-helical stem region
which forms the core of the HA homotrimer, whereas most
of the HA1 subunits form globular domains located on top
of the stem region. The fusion peptide is located 100 A˚ from
the distal top and 35 A˚ from the viral membrane end of the
molecule and cannot reach the viral or target membrane
unless a major conformational change occurs within the
protein.
Although the structure of BHA at low pH is not available,
an enzymatically digested form of HA has been crystallized
and solved (TBHA2) (Bullough et al., 1994). Each monomer
of the TBHA2 consists of residues 38–175 of HA2 and 1–27
of the HA1, linked by disulﬁde bonds. Comparison between
the neutral (BHA) and low pH (TBHA2) structures of
hemagglutinin revealed a dramatic conformational change.
The most remarkable observation is a growth of the triple-
stranded, a-helical coiled coil due to incorporation of the
random coil region (residues 56–75) and a second a-helix
(residues 38–55) into the coiled coil. This growth of the
coiled coil stem was predicted based on the amino acid
sequence before the structure was solved (Carr and Kim,
1993). This conformational change in TBHA2 seems to
allow the N-terminus of HA2 to interact directly with the
target membranes. In addition, there is a helix-to-loop
transition (HA2:105–112) which allows the polypeptide
chain to reverse direction near its C-terminus. A somewhat
longer portion of HA at low pH has also been solved (Chen
et al., 1999). Similar trimeric coiled coils have been observed
in the structures of other viral membrane fusion proteins
(Hughson, 1997). It is not clear whether these correspond to
the fusogenic conformation or the ﬁnal conformation after fu-
sion. In the case of HIV there is evidence that six-helix bun-
dle formation occurs together with membrane fusion, i.e., the
Submitted August 1, 2002, and accepted for publication November 18,
2002.
Address reprint requests to Themis Lazaridis, Tel.: 212-650-8364; Fax:
212-650-6107; E-mail: themis@sci.ccny.cuny.edu.
 2003 by the Biophysical Society
0006-3495/03/03/1926/14 $2.00
six-helix bundle is the postfusion conformation (Melikyan
et al., 2000).
The structure of a mutant, uncleaved precursor (HA0) was
also determined by x-ray crystallography (Chen et al., 1998).
Only 19 residues bracketing the cleavage site are located
differently in HA0 relative to BHA. The remaining residues
in HA0 are essentially superimposable to BHA. Whereas the
cleaved HA undergoes a low-pH induced conformational
change (Bullough et al., 1994), the uncleaved precursor HA0
is stable at low pH (Chen et al., 1998).
Many studies have aimed to understand the role of the
fusion peptide in viral fusion (Lear and DeGrado, 1987; Han
and Tamm, 2000; Bechor and Ben-Tal, 2001). It is thought
that the fusion peptide inserts into the cell membrane and
destabilizes the bilayer (Skehel et al., 1982). Point mutations
in this peptide can block membrane fusion (Durell et al.,
1997). It has been proposed that the fusion peptide is ob-
liquely inserted into the target membrane as a ﬂexible mono-
mer in an a-helical conformation (Brasseur et al., 1997).
EPR studies suggest that the fusion peptide is an a-helix
tilted ;258 from the horizontal plane of the membrane
(Macosko et al., 1997). More recent studies also found ob-
lique orientations (Bradshaw et al., 2000; Han and Tamm,
2000). Recently, Tamm and co-workers determined the HA
fusion domain structure in micelles (Cohen and Melikyan,
2001; Han et al., 2001) and their results suggested a helix-
break-helix structural motif for the fusion domain of
inﬂuenza HA at pH 5.
Several models have been proposed for the mechanism of
membrane fusion. One model proposes a localized confor-
mational change, resulting in the exposure of the fusion
peptide, while maintaining the intact hairpin structure of the
HA2 chain (Stegmann et al., 1990). In this model the fusion
peptide can insert into the target membrane by tilting of the
HA trimer. Another model (Bentz et al., 1990) proposed that
the exposed fusion peptides from a cluster of HA trimers
induce the formation of an inverted micelle in the space
between them. The spring-loaded model (Carr and Kim,
1993; Bullough et al., 1994), which currently seems to be
the most widely accepted, assumes a global conformation
change in HA similar to the one observed in the x-ray crystal
structure of TBHA2 (Bullough et al., 1994). Many variations
of these models exist in the literature (Bentz, 1992;
Chernomordik et al., 1998; Kozlov and Chernomordik,
1998; Shangguan et al., 1998; Bentz, 2000; Bonnafous and
Stegmann, 2000).
The goal of this work is to test the spring-loaded model by
calculating possible pathways for the conformational change
in HA by computer simulations. We use the two crystal
structures (1HGF and 1HTM) as initial and ﬁnal states and
try to ﬁnd a path between them with targeted molecular
dynamics (TMD; Schlitter et al., 1993; Apostolakis et al.,
1999). This technique has been used to study the reaction
paths for conformational changes in ras p21 (Diaz et al.,
1997; Ma and Karplus, 1997), protein folding and unfold-
ing (Ferrara et al., 2000a,b), conformational changes in
DNA polymerase (Yang et al., 2002), and the rotation of the
g-stalk in F1-ATPase (Bockmann and Grubmuller, 2002; Ma
et al., 2002). Because of the incomplete crystal structure of
the low-pH HA, TMD is applied only on the residues avail-
able in the low-pH crystal structure while allowing the rest of
the molecule to freely adjust to the conformational changes
in the core.
METHODS
Molecular dynamics simulations were carried out using the program
CHARMM (Brooks et al., 1983). In a large system like hemagglutinin, it is
computationally prohibitive to treat water explicitly. In this work we use
the effective energy function EEF1, based on the CHARMM 19 polar
hydrogen force ﬁeld (Neria et al., 1996), which provides a reasonable
approximation for proteins in aqueous solution (Lazaridis and Karplus,
1999). In this method, the solvation free energy of a protein is assumed to
be the sum of group contributions, which are determined from experimental
data for small model compounds. In addition, all ionic side chains are
neutralized and a distance-dependent dielectric constant is used to
approximate the charge-charge interactions in solution. The van der Waals
and electrostatic potentials are truncated at 9 A˚ with a switching function
starting at 7 A˚. Inasmuch as the HA conformational change occurs also at
neutral pH (by increased temperature or denaturants; Carr et al., 1997), we
do not consider changes in pH and the concomitant variations in the
protonation state of ionizable residues. In this article, by energy we will
refer to the effective energy, i.e., the sum of the intramolecular energy and
the solvation free energy.
The pathway from native to putative low-pH model HA conformation
was obtained by the method of targeted molecular dynamics (Schlitter et al.,
1993; Apostolakis et al., 1999). In TMD, simulations are performed with
a restraint aimed to force the system to sample conformations with a desired
RMSD from a target conformation. This is accomplished by adding
a harmonic potential energy term of the form
Ures ¼ KðRMSDf  rÞ2;
where K is a force constant, RMSDf is the root-mean-square deviation from
the target structure, and r is the desired RMSD value. In this work we use the
implementation of TMD in CHARMM by Caﬂisch and co-workers
(Apostolakis et al., 1999). The initial value of r is usually taken as the
RMSD between the initial and ﬁnal structures. During the simulation r is
gradually decreased to zero, thus forcing the system from the initial to the
ﬁnal structure. To avoid rigid body translational and rotational motion, the
Eckart conditions are applied to the system in the form of holonomic
constraints (Apostolakis et al., 1999).
The starting point of the TMD simulations was the crystal structure of
native Hemagglutinin (pdb entry 1HGF). Simulations were performed at
a mean temperature of 300 K. Because the conformational change at hand
is very large, it is not possible to force the whole trimer to its ﬁnal
conformation in one step. Instead, we carried out the TMD simulations
gradually. In both the native HA and TBHA2 the residues 76–105 of HA2
have the same structure. Thus initially, only this region was included in the
RMSD restraint for 100 ps. At the end of the simulation, the RMSD
between the initial and ﬁnal targeted peptide chain was less than 1.0 A˚. In
subsequent stages, the portion of TBHA2 included in the TMD restraint
was gradually increased. This can be done in different ways, resulting to
alternative paths.
In the present study, three pathways have been constructed. 1), For the
ﬁrst path, the low-pH structure was built simultaneously from both ends of
the identical structure (HA2:76-105). Thus in each subsequent TMD step,
four more amino acids from both ends of the previous segment were
included in the RMSD restraint. It took 15 TMD steps to build the low pH
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model of HA from the neutral pH structure of BHA in this way. 2), An
intermediate with the coiled coil extending toward the target membrane but
without the reversal of direction at the C-terminal end of HA2 has been
proposed (Hernandez et al., 1996; Hughson, 1997; Eckert and Kim, 2001).
To incorporate such an intermediate in the reaction pathway, Path 2 was
constructed in two stages. In the ﬁrst stage, the coiled coil was extended in
the N-terminal direction (10 steps) and in the second stage the reversal at the
C-terminal end of HA2 was effected (15 steps). 3), Experimental studies
suggested a dissociation of the globular domains of HA at low pH (Godley
et al., 1992; Kemble et al., 1992). Therefore, in Path 3 the centers of mass of
the globular domains were ﬁrst moved to a distance of 50 A˚, followed by
100-ps dynamics. The resulting structure was then subjected to TMD as in
Path 1.
As a control, the same TMD simulations were performed on the
uncleaved precursor HA0 (pdb entry 1HA0). Based on crystallographic
symmetry, a trimer of HA0 was built using the program TINKER (Ponder,
2001). The simulation protocol used in Path 1 was used for the HA0 !
1HTM transformation. In all cases, each step of the TMD simulations
consisted of 100 ps and the RMSDs between the ﬁnal structures from the
target was found to be less than 1.0 A˚. The ﬁnal structures obtained at the
end of the complete TMD simulations are our model low-pH hemagglutinin
structures. The models obtained from Path 1, Path 2, and Path 3 are referred
to as HAlowpH1, HAlowpH2, and HAlowpH3, respectively, and the model
obtained for HA0 is referred to as HA0lowpH.
The TMD restraints introduce substantial strain into the protein struc-
tures. As a result, the TMD structures may have artiﬁcially high energies.
To obtain more realistic energetic estimates, all structures along the TMD
paths were subjected to a 200-ps unconstrained dynamics simulation, check-
ing that they remain close to their starting conformations. The resulting dyna-
mics structures were once again minimized for 300 Adopted Basis Newton-
Raphson (ABNR) steps. We refer to these structures as the relaxed structures
and to the pathways composed by these structures as the relaxed pathways.
One major advantage of using implicit solvation is that the relative
probability of different conformations is given by the Boltzmann factor of
the difference in effective energy between the two conformations (Lazaridis
and Karplus, 1999). In reality, protein conformational states consist not of
one but of an ensemble of conformations. The probability of each state
depends on the average effective energy, which is readily obtained using
implicit solvation, and the conformational entropy of the state, i.e., the
number of conformations that belong to that state (Lazaridis and Karplus,
2001). In this paper we evaluate effective energies and only qualitatively
discuss possible differences in conformational entropy. We emphasize that
only differences in energy between different conformations are meaningful,
not the absolute values of the energy.
We also report the effective energy of the ﬁnal structure after 300 energy
minimization steps using the ABNR method. Although not rigorous, this is
a fast and convenient way to assess the energetics of a conformational state.
From our experience, minimized energies and average energies usually give
the same trends. The reason for choosing 300 steps is that the largest
decrease in energy in ABNR occurs in the ﬁrst 200 steps. More extensive
minimizations change the absolute values of the energy but not so much the
relative energy of different conformations. For example, the difference
between 1HGF and relHAlowpH1 in Table 3 using 300 steps is 144 kcal/mol.
Using 500 steps this difference is 166 kcal/mol and using 1000 steps it is 187
kcal/mol. The difference between the average effective energies is 183 kcal/
mol. Here the 1000-step result agrees best with the average energies but this
is not always the case.
Average effective energies over an MD simulation are sensitive to the
temperature. When the average temperatures in the simulations of two
conformations are slightly different, a systematic bias is introduced in the
results. The values reported in Tables 1, 3, and 4 have been corrected in
the following way. Additional simulations were done at 295 K and 305 K
and the results (hWi versus hTi) were ﬁtted to a straight line. This line
was then used to obtain the effective energy that corresponds to hTi ¼
300 K.
RESULTS
Energetics of 1HTM relative to 1HGF
It has been proposed that the proteolyzed native form of
HA is metastable. As a ﬁrst step toward characterizing the
energetics of the conformational change, MD simulations of
1HTM and the corresponding fragment from 1HGF were
performed. 1HTM consists of residues 12–16:A, 40–153:B,
11–16:C, 40–162:D, 10–17:E, and 40–162:F. By deleting
from 1HGF the residues that are not present in 1HTM we
created a model named 1HGF1HTM. The two systems were
initially energy-minimized for 300 ABNR steps, followed by
100 ps dynamics. The RMSDs of the heavy atoms in the ﬁnal
1HTM and 1HGF1HTM structures from their initial mini-
mized structures were 2.6 A˚ and 5.6 A˚, respectively. The
large RMSD of 1HGF1HTM is apparently due to the absence
of the rest of the protein, which stabilizes its conformation.
The 100-ps dynamics structures were again minimized for
300 ABNR steps and the energies of the ﬁnal structures, as
well as average energies over the last 5 ps of the 100 ps
dynamics, were calculated. Simulations were also done
using the Generalized Born (GB) model implemented in
CHARMM (Dominy and Brooks, 1999). In this case, the
heavy atoms RMSDs of 1HTM and 1HGF1HTM from their
initial minimized structures were 2.6 A˚ and 6.9 A˚, re-
spectively. The results are shown in Table 1. Both the EEF1
and GB models show that the total energy of 1HTM (mini-
mized or dynamic average) is lower than that of 1HGF1HTM,
i.e., the low pH conformation of the coiled coil part of HA by
itself is energetically more stable than the native conforma-
tion. This is probably due to the extended coiled coil structure
in 1HTM. This result is consistent with the experimental
observation that in the absence of HA1, HA2 folds into the
low pHconformation (Carr andKim, 1993;Chen et al., 1995).
The energy components are also shown in Table 1. With
TABLE 1 Comparison of the energies of 1HTM and 1HGF1HTM
Energy
(kcal/mol) 1HTM 1HGF1HTM Difference
Total
EEF1 13469 (11109) 13291 (10949) 178 (160)
GB 28523 (25207) 28367 (25070) 156 (137)
van der Waals
EEF1 3044 (2757) 2957 (2697) 87 (60)
GB 3450 (3107) 3258 (2947) 192 (160)
Electrostatic
EEF1 7264 (6737) 7245 (6712) 19 (25)
GB 19807 (18625) 20111 (19298) 304 (673)
Solvation
EEF1 3942 (4051) 3872 (3994) 70 (57)
GB 5949 (6816) 5713 (6186) 236 (630)
Covalent
EEF1 781 (2436) 783 (2455) 2 (19)
GB 683 (3341) 715 (3360) 32 (19)
The values in parentheses are average energies over the last 5 ps of
dynamics.
1928 Madhusoodanan and Lazaridis
Biophysical Journal 84(3) 1926–1939
EEF1, all energy terms are lower in 1HTMthan in1HGF1HTM.
With GB all but the electrostatic energy term are lower for
1HTM.
Reaction pathways and ﬁnal low pH models
In the ﬁrst pathway, the low-pH model was sequentially built
simultaneously from both ends of the identical segments
(HA2:76–105). After each TMD step, the RMSDs of the
targeted peptide chains from the corresponding 1HTM
fragment were less than 0.5 A˚. The structure obtained at
the end of all 15 steps of TMD is referred to as tmdHAlowpH1.
The RMSD between 1HTM and the corresponding residues
in tmdHAlowpH1 was 0.3 A˚. Thus, the TMD method suc-
ceeded in converting 1HGF into a structure that contains
the 1HTM core. Fig. 1 shows structures of HA along Path 1,
highlighting the position of the fusion peptides (in black). In
the native state of HA (Fig. 1A), the fusion peptide is located
;35 A˚ away from the viral membrane (bottom of the ﬁgure)
buried in the trimeric coiled coil. At step 3 (Fig. 1 B) the
location of the fusion peptide did not change much. The
most signiﬁcant change in structure occurs around residue
HA2:106 where the coiled coil is forced to break and reverse
direction. In the sixth step (Fig. 1 C), where HA2:56–125
residues were targeted, the loop between the inner and outer
helices in the lower part of the molecule is formed. At this
stage, the fusion peptides are displaced from their original
position, with one fusion peptide moving toward the viral
membrane. At the end of the ninth step (Fig. 1D), this fusion
peptide remained almost in the same region, another fusion
peptide became exposed and the third fusion peptide moved
upwards. In the 12th step (Fig. 1 E), the fusion peptide which
was near the lower region of the HA moved upward and
became exposed completely. The other two fusion peptides
also moved upwards and into the interface between the
globular domains and the coiled coil. This arrangement is
preserved in the ﬁnal structure (Fig. 1 F). Complete dis-
sociation of the globular domains is not observed in this path.
The second pathway was generated in two stages. In
the ﬁrst stage, the coiled coil was extended toward the
N-terminus of HA2 and in the second stage breaking of the
long helix in the lower part of HA2 chain was effected.
This pathway produced intermediate structures which are
very different from those generated by Path 1. The structural
changes of HA along this path are shown in Fig. 2. At the
fourth step (Fig. 2A) the globular domains moved only a few
A˚ away from their original positions. However, by the end of
the ﬁfth step (Fig. 2 B), the globular domains became widely
separated. At the end of the ﬁrst stage, i.e., in the 10th TMD
step (Fig. 2 C), the globular domains remained widely
separated and the fusion peptides became stretched. Toward
the end of the ﬁrst stage tilting of the trimeric coiled coil with
respect to the lower part of the coiled coil (HA2:105–125 in
1HGF) was observed. In the second stage (Fig. 2 D, 15th
step), the fusion peptides started moving upward and one of
the globular domains moved toward the viral membrane. All
the fusion peptides were exposed at the 20th TMD step (Fig.
2 E). At the end of the TMD simulation (Fig. 2 F), one of the
fusion peptides was at the tip of the coiled coil and the other
two fusion peptides were almost completely exposed so that
they could easily attach to a target membrane. The complete
dissociation of the globular domains in the ﬁrst stage of this
path is probably due to the fact that the lower part remains
intact and pulls the globular domains down and out as the
coiled coil penetrates through their interface.
FIGURE 1 Ribbon representation of the structure of HA along TMD Path
1 for the 1HGF! 1HTM transformation: (A) at step 0, (B) at step 3, (C) at
step 6, (D) at step 9, (E) at step 12, and (F) at step 15. The segments in black
are fusion peptides.
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In Path 3, the centers of mass of the globular domains
were ﬁrst separated by 50 A˚ and continued to maintain this
separation along the pathway. This conformation was ;260
kcal/mol higher than native HA. After this initial displace-
ment, the restraints proceeded as in Path 1. Conformational
changes of HA during this pathway are presented in Fig. 3.
Fig. 3 A is the initial structure of HA in Path 3, where the
globular domains are separated by 50 A˚. In the third step
(Fig. 3 B), the fusion peptides have not moved much from
their original position but the coiled coil has moved upward
into the interface of the globular domains. In the sixth step
(Fig. 3 C) the fusion peptides moved out of their original
positions. In the ninth step (Fig. 3 D), the fusion peptides
were still in the lower half of the HA. Fig. 3, E and F show
one of the fusion peptides located at the upper region of HA.
The other two fusion peptides became fully exposed; one of
FIGURE 2 Ribbon representation of the
structure of HA along TMD Path 2 for the
1HGF! 1HTM transformation: (A) at step
4, (B) at step 5, (C) at step 10, (D) at step
15, (E) at step 20, and (F) at step 25. The
segments in black are fusion peptides.
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them moved toward the lower region of HA and the second
remained in the lower half of HA but away from the viral
membrane. Although the globular domains were initially
separated, passage of the fusion peptide through their in-
terface was not observed. However, unlike in the ﬁrst path-
way, full penetration of the coiled coil in the interface of
globular domains was observed.
Because HA0 is stable at low pH (Chen et al., 1998) it can
be used as a control experiment. Thus, the 1HTM core
structure was built into the precursor HA0 in 15 steps of
TMD as in the Path 1. The model obtained from HA0 is
called tmdHA0lowpH. Structural changes of HA0 along this
pathway are shown in Fig. 4. At step 3, even though the
coiled coil breaks and reverses direction (Fig. 4 B), the
fusion peptides remained close to their original positions.
Some displacement of the fusion peptides was observed at
the end of the sixth step (Fig. 4 C) and the ninth step (Fig. 4
D), with one fusion peptide moving toward the viral
membrane. At step 12, (Fig. 4 E) the fusion peptide near
the viral membrane returned near its original position. In the
ﬁnal step (Fig. 4 F), all the fusion peptides were near their
original positions. In this pathway, a small separation of
the globular domains was observed. A slight slanting of the
globular domains was also seen, with one of the globular do-
mains placed right on top of the coiled coil.
Our ﬁnal low pH models result from a 200-ps un-
constrained simulation of the ﬁnal TMD structures and they
are called relHAlowpH1,
relHAlowpH2,
relHAlowpH3, and
relHA0lowpH for Path 1, Path 2, Path 3, and the HA0 !
1HTM transformation, respectively. The RMSDs of the
1HTM core from the crystal structure in all the ﬁnal TMD
models were less than 1.0 A˚. The RMSDs of the 1HTM core
in the relaxed models were 2.03 A˚, 3.07 A˚, 4.0 A˚, and 11.3 A˚
for relHAlowpH1,
relHAlowpH2,
relHAlowpH3, and
relHA0lowpH
structures, respectively. The RMSDs of the targeted residues
of 1HTM core in the relaxed intermediate structures were
also determined. They were less than 3 A˚ for all the in-
termediate structures of relaxed Path 1, Path 2, and Path 3,
but between 8 A˚ and 10 A˚ for many of the intermediate
structures of relaxed pathway for HA0 ! 1HTM trans-
formation. This is due to the large amount of strain in the
HA0 intermediate structures which is relieved only by large
deformations. During the conformational change the glob-
ular HA1 domains move more or less as rigid bodies (see
below).
In the native state the fusion peptides are located ;100 A˚
from the distal tip and ;35 A˚ from the viral membrane. In
the ﬁrst low pH model, two of the fusion peptides moved
toward the distal tip of the molecule (closer to the target
membrane), and the third fusion peptide became exposed but
remained close to its original position. The RMSD values of
the globular domains (Table 2) indicate that two of them in
relHAlowpH1 retained their overall structure but the third
showed a larger deformation with an RMSD of 5.9 A˚.
In the second low pH model the fusion peptides ex-
perienced large movements. In this model, one of the fu-
sion peptides moved toward the distal tip of the fusogenic
HA. The other two fusion peptides also moved in the upward
direction and were exposed, becoming available for an-
choring to the target membrane. A large separation of the
FIGURE 3 Ribbon representation of the structure of HA along TMD Path
3 for the 1HGF! 1HTM transformation: (A) at step 0, (B) at step 3, (C) at
step 6, (D) at step 9, (E) at step 12, and (F) at step 15. The segments in black
are fusion peptides.
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HA1 globular domains was seen, with one of them reach-
ing toward the viral membrane. Although the HA1 domains
moved a long distance from their original positions, they
largely retained their native structures (RMSDs were 3.0 A˚,
3.8 A˚, and 4.9 A˚).
Because the globular domains were initially separated, the
trimeric coiled coil in the third low pH model could
pass through the interface of the globular domains. All the
fusion peptides in this model were exposed. One of them
moved toward the target membrane, going around one of
the globular domains. Another fusion peptide moved toward
the viral membrane and the third fusion peptide remained
around the middle of the molecule but outside the long
trimeric coiled coil. In this model two of the globular do-
mains also retained their original structures and the third
domain exhibited a larger distortion with an RMSD of 5.0 A˚
(Table 2).
The low pH model of HA0 was essentially denatured. The
1HTM structure built into the HA0 was destroyed during the
relaxation process. The denaturation of the ﬁnal low-pH
model of HA0 is probably due to the presence of a large
amount of strain developed during the TMD simulations.
Despite this, the globular domains remained close to native
(Table 2). The globular domains consist of several b-sheets
and they are located in an isolated top region of HA. A
drastic conformational change of this domain requires a lot
of energy, which may be the reason why these domains re-
tained their tertiary structures in our low pH models. The fu-
sion peptides remained close to their original positions.
Fig. 5 shows the top view of the globular domains of
the native, relHAlowpH1, and
relHAlowpH3 states. In the native
state (Fig. 5 A), the globular domains form a triangular inter-
face with their centers of mass separated by ;33 A˚. In
relHAlowpH1 most of the secondary structure is still present
but one can see a slight opening up of the globular domains;
one side of the triangle is;53 A˚ in length whereas the other
two sides are ;41 A˚ and 36 A˚, respectively. Fig. 5 C shows
that the secondary structures of two globular domains in
relHAlowpH3 are well retained whereas some distortion (see
Table 2) has occurred in the third globular domain.
Energetics of the low-pH models and
energy barriers
Fig. 6 shows the behavior of the minimized energy along the
TMD pathways. Large increases in energy are observed as
FIGURE 4 Ribbon representation of the structure of HA0 along TMD
path for the HA0! 1HTM transformation: (A) at step 0, (B) at step 3, (C) at
step 6, (D) at step 9, (E) at step 12, and (F) at step 15. The segments in black
are fusion peptides.
TABLE 2 RMSDs of the HA1 globular domains in native HA
from the ﬁnal low-pH models of HA and HA0
Globular
domain
RMSD, A˚
relHAlowpH1
RMSD, A˚
relHAlowpH2
RMSD, A˚
relHAlowpH3
RMSD, A˚
relHA0lowpH
HA1:60–260.A 5.9 3.0 5.0 2.1
HA1:60–260.C 2.0 4.9 2.2 4.3
HA1:60–260.E 2.8 3.8 2.3 2.7
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FIGURE 5 Top view of the ribbon diagram of the globular domains: (A) native HA, 1HGF; (B) low-pH HA of Path 1; and (C) low-pH HA of Path 3.
FIGURE 6 Energy proﬁles along the TMD and relaxed pathways of (A) Path 1, 1HGF ! 1HTM transformation; (B) Path 2, 1HGF ! 1HTM
transformation; (C) Path 3, 1HGF ! 1HTM transformation; and (D) HA0 ! 1HTM transformation. Note the different energy scale in D.
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we move away from the native state with the ﬁnal TMD
models being higher in energy than the native HA by
hundreds of kcal/mol. The barrier states of Path 1 and Path 3
are only slightly higher than the ﬁnal states. These energies
are artiﬁcially high, probably due to the strain introduced
into the protein molecules by the TMD restraints.
Unrestrained MD simulations were used to relax the TMD
structures. The energy proﬁles along these relaxed pathways
have much lower energy barriers, of the order of 170–250
kcal/mol (dashed lines in Fig. 6). Since unrestrained MD
simulations produce locally stable states, these barriers
correspond to high energy basins and not transition states.
Thus the energy barriers estimated this way are lower bounds
for the true barriers. On the other hand, these paths are not
optimal, minimum-energy paths and therefore may have
barriers higher than those of the optimal paths. Also, these
values may be too high because they do not include the
usually favorable activation entropy contribution.
In Path 1, the highest barrier is found at the ninth TMD
step and is 214 kcal/mol higher than the initial state. Along
Path 2, two barriers are seen, one at the 10th step (242 kcal/
mol) and another at the 20th step (252 kcal/mol). The low
energy state at the 16th step, which is only 51 kcal/mol
higher than the initial state, could be thought of as an
intermediate along this path. The highest barrier of Path 3 is
at the 12th step (;170 kcal/mol). In all cases, analysis of the
energy components shows that the van der Waals energy
makes the largest contribution to the barriers.
Fig. 6D shows the energy proﬁle along the pathway of the
HA0 ! 1HTM transformation. In this case the TMD
pathway has an energy barrier much higher than those of the
HA pathways. Similarly, the ﬁnal state is 2061 kcal/mol
higher in energy than the initial state, almost three times
higher than energy difference between the ﬁnal and initial
states of all the three pathways of the HA ! 1HTM
transformation. Unrestrained simulations of the structures
along the TMD path led to large deviations from the target
structure. The total energy of the relaxed low pH HA0 is
;272 kcal/higher than the initial HA0.
The minimized energies as well as the average energies
over the last 5 ps of dynamics of the initial and ﬁnal low-pH
models of HA are given in Table 3. Both the minimized and
average energies of the low pH models are only slightly
higher in energy than the native state (in fact, the minimized
energy of model 2 is lower than that of the native state).
Given the limited simulation time and extent of conforma-
tional search used in the simulations, the results indicate that
the low pH models are very competitive in energy compared
to the native state. Table 4 gives the energetics of the initial
and ﬁnal states of the HA0! 1HTM transformation. In this
case, both the minimized and dynamic average energies of
the low-pH model of HA0 are signiﬁcantly higher than those
of the initial state. This supports the hypothesis that 1HGF is
the global minimum energy conformation for the uncleaved
precursor but a metastable state for cleaved HA.
Comparison with experimental data
In this section we examine the consistency of our low-pH
structures with available experimental data, namely anti-
genicity changes, fusion activity of crosslinked mutants,
electron microscopy, changes in proteolytic susceptibility,
and other spectroscopic studies like circular dichroism and
ﬂuorescence.
Antigenicity changes at low pH
HA has four major antigenic sites labeled A, B, C, and D
(Wiley et al., 1981), all located in the HA1 chain. Site A is
a loop from amino acids 140 to 146, which protrudes 8 A˚
from the local molecular surface. Site B comprises the
external residues 187–196 of an a-helix and adjacent
residues along the upper edge of a pocket. Site C is a bulge
in the tertiary structure at the disulﬁde bond between Cys 52
and Cys 277 which is 60 A˚ from the distal tip of the
molecule. Site D is located in the interface of the globular
domain ranging from amino acids 201 to 215. Experiments
have shown that the antigenic sites A and C are not irre-
TABLE 3 Energetics of the initial (1HGF) and ﬁnal low-pH models of HA
Energy (kcal/mol) 1HGF relHAlowpH1
relHAlowpH2
relHAlowpH3
Total 48634 (39548) 48490 (39365) 48697 (39485) 48571 (39460)
van der Waals 11707 (10721) 11252 (10296) 11360 (10414) 11608 (10688)
Electrostatic 27588 (25654) 27768 (25687) 27933 (25791) 27916 (25851)
Solvation 13143 (13499) 13285 (13699) 13188 (13593) 13006 (13367)
Covalent 3804 (10326) 3815 (10316) 3783 (10313) 3959 (10445)
The values in parentheses are the average energies over the last 5 ps of dynamics.
TABLE 4 Energetics of the initial (HA0) and ﬁnal low-pH model
of HA0
Energy
(kcal/mol) HA0 tmdHA0lowpH
relHA0lowpH
Total 47605 (38551) 45270 (32057) 47332 (38011)
van der Waals 11416 (10449) 11016 (10118) 10960 (10192)
Electrostatic 27258 (25235) 26388 (24721) 27198 (25194)
Solvation 12742 (13114) 12625 (12810) 13016 (13256)
Covalent 3811 (10247) 4759 (15592) 3841 (10631)
The values in parentheses are the average energies over the last 5 ps of
dynamics.
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versibly affected antigenically (Daniels et al., 1983), whereas
the antigenicity of sites B and D is lost (100- to 1000-fold)
when hemagglutinin is subjected to low-pH treatment
(Daniels et al., 1983; Webster et al., 1983). However, an-
other study observed, with few exceptions, only a slight (5–
10 fold) reduction in the reactivity of antigenic sites B and D
with pH-5 treated virus (Yewdell et al., 1983).
For a given antigenic site to be active at low pH, the site
must be available to the antibody in the same conformation
as in the native state. Based on this assumption, the RMSDs
of the antigenic sites in all three model low-pH HAs from
their conformation in native HA were calculated (Table 5).
Antigenic sites A and C from the three polypeptide chains
are quite far from each other and probably bind to their
antibodies individually. Sites B and D are located at the top
and interface of the globular domains and all three sites of
B or D can be accessed simultaneously by antibodies. Since
sites A and C bind as monomers to their antibodies, their
RMSDs are calculated from each chain of HA1 separately.
For sites B and D, the RMSDs are calculated both
individually from each chain and also from all the chains
together.
In all three pathways, RMSDs of the antigenic sites A and
C in each HA1 chain are less than 1.5 A˚, which indicates that
the conformations of these antigenic sites are well retained in
their low pH models and can readily bind the antibodies. The
individual RMSDs of antigenic sites B and D from each
chain are less than 2.5 A˚, except for the two antigenic D sites
in the second low pH model which are[3.5 A˚. However,
when the RMSD was calculated with all the chains together,
the antigenic sites B and D in all the low-pH models showed
large deviations ([7.3 A˚) from the native state. These large
RMSDs indicate the degradation of these antigenic sites,
which can abolish antigenicity. These experimental data are
consistent with all three low-pH HA models. If sites B and D
are involved in monomeric binding, then the RMSD values
indicate a slight change in the antigenicity as observed by
Yewdell et al. (1983). This result indicates that perhaps sites
B and D are involved in trimeric or monomeric binding
depending on the antibody.
White and Wilson (1987) compared the reactivity of
antipeptide antibodies to neutral and low-pH treated BHA.
At pH 5.0 and pH 4.6 they saw an increase in antibody
reactivity for the antigenic sites A, B, C, and D, due to
exposure of the individual peptide segments in con-
formations suitable for antibody binding. We have calculated
the solvent-accessible surface area of these sites in the na-
tive and the low-pH HA using the MOLMOL program
(Koradi et al., 1996). As the antigenic sites A and C are
already in the peripheral region, the surface-accessible area
did not change much for these sites. However, the surface-
accessible area of the antigenic sites B and D increased in
the low-pH model of HA. Average solvent-accessible sur-
face area (SASA) of antigenic site B in the native state is
;18%. In the low pH models it increased to 25%, 26%,
and 23% for models 1, 2, and 3, respectively. Similarly, av-
erage SASA of antigenic site D in the native state is
;23%. This value increased to 31%, 32%, and 29% for low
pH models 1, 2, and 3, respectively. This increase in SASA
is due to the partial or complete opening up of the globu-
lar domains in all the low-pH models. Increase in the surface
accessible area of sites B and D is consistent with the
experimentally observed increase in the reactivity of
antipeptide antibody binding at low pH (White and Wilson,
1987).
Membrane fusion activity of crosslinked mutants
Introduction of intersubunit disulﬁde bonds, by mutating
HA1:212 and HA1:216 to cysteines, in the membrane-distal
region of HA inhibited the low-pH induced conformational
changes and prevented the HA-mediated membrane fusion
presumably by restricting the dissociation of the globular
domains (Godley et al., 1992; Kemble et al., 1992). Con-
ditions that reduced the novel disulﬁde bonds restored the
membrane fusion activity. This experiment suggests that at
least a partial dissociation of the distal globular domains is
essential for membrane fusion activity.
In our model low-pH HAs, partial dissociation of the
globular head domains is seen in tmdHAlowpH1 and a complete
dissociation of the globular domains is seen in tmdHAlowpH2.
In BHA the distance between the Cas of the intersubunit
residues HA1:212 and HA1:216 is ;6.3 A˚. In tmdHAlowpH1
one pair of intersubunit residues retained its original distance
and the other two pairs were separated by 23.1 A˚ and 13.8 A˚,
indicating the partial opening up of the globular domains. In
tmdHAlowpH2 these distances were very large for two pairs of
intersubunit residues and the third pair was ;8 A˚ away. In
the third low-pH HA model, all the intersubunit residues
TABLE 5 RMSD of the antigenic sites A, B, C, and D in the
ﬁnal low-pH HA models from the native HA
Antigenic site
RMSD, A˚
(Path 1)
RMSD, A˚
(Path 2)
RMSD, A˚
(Path 3)
A HA1:A, 0.92 HA1:A, 1.35 HA1:A, 1.41
HA1:C, 0.65 HA1:C, 1.09 HA1:C, 0.99
HA1:E, 0.93 HA1:E, 0.59 HA1:E, 0.51
B HA1:A, 1.50 HA1:A, 2.00 HA1:A, 1.32
HA1:C, 0.82 HA1:C, 1.45 HA1:C, 1.43
HA1:E, 2.50 HA1:E, 1.57 HA1:E, 1.07
HA1:A, C,
and E, 9.6
HA1:A, C,
and E, 50.4
HA1:A, C,
and E, 17.9
C HA1:A, 1.50 HA1:A, 0.35 HA1:A, 0.84
HA1:C, 0.26 HA1:C, 0.25 HA1:C, 0.28
HA1:E, 0.28 HA1:E, 0.269 HA1:E, 1.33
D HA1:A, 1.58 HA1:A, 1.09 HA1:A, 0.89
HA1:C, 1.11 HA1:C, 7.54 HA1:C, 0.83
HA1:E, 1.39 HA1:E, 3.35 HA1:E, 1.43
HA1:A, C,
and E, 7.3
HA1:A, C,
and E, 47.2
HA1:A, C,
and E, 13.7
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HA1:212 and HA1:216 were separated by ;33 A˚. Thus,
crosslinking between 212 and 216 is incompatible with all
three putative low-pH models.
Electron microscopy
Electron microscopy on BHA at pH 7 showed a spike length
of 13.7 nm, consistent with the x-ray structure (Ruigrok et al.,
1986) Low pH leads to formation of rosettes presumably
due to the extrusion of the fusion peptides (Skehel et al.,
1982; Ruigrok et al., 1986) and an increment of 3.7 nm in
spike length (Ruigrok et al., 1986). It has been suggested that
the fusion peptides are either extruded sideways or toward
the membrane proximal end of the molecule (Ruigrok et al.,
1986). Thermolytic digestion of the amino terminal region
resulted in shortening of BHA2 and suggested that the amino
terminus of HA2 moves to the membrane proximal region
of the molecule (Ruigrok et al., 1988). In our low-pH HA
models we observe some of the fusion peptides moving
to the distal tip of the trimeric stem and some extruded
sideways. In these models an increment of HA length is also
seen compared with the length of native HA, mainly due to
the extension of the trimeric coiled coil. Electron cryomicro-
scopy on HA at fusogenic pH has shown ﬂattening of the
distal top HA1 domains and formation of a continuous
central cavity through the whole trimer (Bo¨ttcher et al.,
1999), which does not seem to be consistent with 1HTM and
our models, which are based on 1HTM.
Analysis of the rosettes at low pH suggested that a single
molecule would have a radius of gyration of 51 A˚ (Ruigrok
et al., 1986). Fig. 7 shows the radius of gyration of the
molecule along each pathway. Along the ﬁrst pathway, the
radius of gyration of the molecule ﬂuctuated a little but in the
ﬁnal low-pH model was similar to that of the native HA. In
Path 2, it increased along the pathway and the ﬁnal low-pH
HA had a radius of gyration of 50.4 A˚, which is very close
to the value predicted for a single molecule at low pH. In con-
trast, the radius of gyration of the molecule decreased along
the third pathway. This observation shows that among the
three models, model 2 is in best agreement with these data.
Changes in proteolytic susceptibility
Incubation of BHA at pH 5.0 showed changes in its sus-
ceptibility to trypsin and produced components of soluble
(BHA1:28-328) and aggregate fractions (BHA2 and prob-
ably BHA1:1-27; Skehel et al., 1982; Doms et al., 1985).
The tryptic cleavage of BHA in the low-pH conformation
occurs ﬁrst at HA1:27 and then at HA1:224. Examination of
these sites of tryptic cleavage in the native BHA structure
shows that the peptide bond at residue 27 is buried behind
residues 32 and 33 near the trimer interface. The peptide
bond at residue 224 may be inaccessible to trypsin due to its
proximity to the trimer interface and the carbohydrate side
chain at residue 165 of the adjacent subunit. A conforma-
tional change affecting subunit interaction could, therefore,
render both residues susceptible to tryptic attack. We have
examined the accessibility of the peptide bond at residue
HA1:27 by measuring the solvent-accessible surface area in
all the three low-pH models and native HA. In all models
these peptide bonds were well exposed compared to BHA.
Average SASA of residues HA1:26–28 in the native state is
;30%. In the low-pH models the exposure of these residues
increased to 51%, 36%, and 43% in models 1, 2, and 3,
respectively. In model 2 the peptide bond at residue 27 of one
of the chains was less accessible than the other two chains
because of its proximity to its globular domain in the ﬁnal
conformation (see Fig. 2). Similarly, the accessibility of the
residue HA1:224 in all low-pH models increased substan-
tially compared to 1HGF. In the native state the SASA of
HA1:224 is;42% and it increased to 57%, 57%, and 50% in
the low-pH models 1, 2, and 3, respectively. This result is in
good agreement with the experimental observations.
Other spectroscopic studies: CD and ﬂuorescence
Circular dichroism (CD) spectra as a function of pH in both
the near and far UV region have shown distinct conforma-
tional features of HA. The far-UV CD spectrum of HA
showed that HA in rosettes maintained its overall second-
ary structure throughout the pH range of 7.4–4.5 (Wharton
et al., 1988; Remeta et al., 2002). This indicates that even
though the crystal structures of native and low-pH HA show
dramatic conformational changes, especially in HA2 chains,
the overall secondary structure was retained at low pH. We
have examined the secondary structures of HA in our low-
pH models. As a measure of how much the secondary
structures are retained in our models we use the ratio
between the number of residues in secondary structures in
the low-pH model and the native state. The number of
FIGURE 7 Radius of gyration of HA along the reaction pathway of HA!
1HTM transformation.
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residues in the secondary structures are obtained from the
secondary structure list created during the ribbon diagram
representation of the molecule by the MOLMOL program. In
the native state the number of residues in a-helices is ;318
and in b-strands ;429. The ratio between the total number
of residues in the a-helices in the low-pH and the native HA
are 0.99, 0.99, and 0.91 for models 1, 2, and 3, respectively.
Similarly, the ratio for b-strands are 0.90, 0.90, and 0.82 for
models 1, 2, and 3, respectively This shows that the overall
secondary structure in our low-pH models is comparable to
the secondary structure of native HA, in agreement with the
far-UV CD studies.
Intrinsic tryptophan (Trp) ﬂuorescence is generally used
for monitoring structural properties and conformational
changes of proteins. In the native state at pH 7.4, the
ﬂuorescence spectrum of HA reﬂected the characteristic
apolar environment of tryptophan. Acidiﬁcation of HA in
rosette structures resulted in exposure of the aromatic
residues (Krumbiegel et al., 1994; Remeta et al., 2002).
We have calculated the solvent-accessible surface area of
Trp in HA1 and HA2 chains in all our low-
pH models. We found that most of the Trp residues that
were buried in the native HA at pH 7.5 got exposed in our
low-pH models. The SASA of all the Trp residues in the
native state and low-pH models are as follows: HA1:Trp84
native ¼ 3.5%, model 1 ¼ 8%, model 2 ¼ 9%, model 3 ¼
18%; HA1:Trp127 native¼ 5%, model 1¼ 22%, model 2¼
17%, model 3¼ 21%; HA1:Trp153 native¼ 8%, model 1¼
19%, model 2 ¼ 18%, model 3 ¼ 21%; HA1:Trp 180 native
¼ 4%, model 1 ¼ 14%, model 2 ¼ 15%, model 3 ¼ 9%;
HA1:Trp222 native ¼ 57%, model 1 ¼ 50%, model 2 ¼
43%, model 3 ¼ 55%; HA1:Trp234 native ¼ 18%, model 1
¼ 30%, model 2¼ 24%, model 3¼ 30%; HA2:Trp14 native
¼ 33%, model 1 ¼ 66%, model 2 ¼ 68%, model 3 ¼ 75%;
HA2:Trp21 native¼ 39%, model 1¼ 61%, model 2¼ 45%,
model 3 ¼ 65%. Fluorescence spectroscopy revealed that
HA2:Trp92 is more buried in the low-pH conformation than
the native HA conformation (Wharton et al., 1988). Solvent-
accessible surface area calculation on this residue also
showed that HA2:Trp92 in all three low-pH models is more
buried than in the native conformation. In the native state, the
SASA of Trp92 was ;51%. In the low-pH models it
decreased to 24%, 25%, and 28% for models 1, 2, and 3,
respectively. Thus, our low-pH models are in agreement with
the ﬂuorescence and CD spectroscopic studies.
DISCUSSION
In the present study the conformational transition of HA
from the native to putative fusogenic or postfusion con-
formations was examined using TMD simulations. Based
on some of the hypotheses proposed in the literature, three
pathways were considered. The main ﬁndings of the present
work, which are consistent with most experimental obser-
vations, are as follows.
1. The effective energy (both EEF1 and GB) of the 1HTM
conformation is lower than that of the 1HGF conforma-
tion for the residues present in 1HTM. This is in ag-
reement with the experimental observation that in the
absence of HA1, HA2 folds into the 1HTM conformation
(Carr and Kim, 1993; Chen et al., 1995).
2. The low-pH model produced by Path 2 is energetically
more probable than the models produced by Paths 1 and
3. The radius of gyration of this model is comparable
with the experimentally suggested value. The main fea-
tures of low-pH model 2 are i) the HA1 globular domains
are widely dissociated; ii) the overall structure of the
head domains is maintained; and iii) the fusion peptides
are exposed and some of them placed toward the tip of
trimeric coiled coil (where the target membrane is
presumably located). The other two models show only
partial separation of the globular domains.
3. Our model low-pH HA0 was higher in energy than the
precursor HA0, supporting the idea that the native con-
formation is the global effective energy minimum for
the uncleaved precursor.
The most probable model (Path 2) has two barriers, one at
the 10th and another at the 20th TMD step. The low energy
state between these two barriers (16th step) can be con-
sidered an intermediate along this path. In this interme-
diate state the coiled coil is fully extended toward the target
membrane with a partial reversal of the C-terminal end of
HA2. This intermediate is similar to the one proposed
based on the spring-loaded mechanism (Hernandez et al.,
1996; Hughson, 1997; Eckert and Kim, 2001). Model 2 has
all the features of the spring-loaded mechanism, i.e., 1) an
intermediate as discussed above; 2) dissociation of the
globular domains, maintaining the overall structure; and 3)
presence of the fusion peptide at the tip of the molecule.
This model is also in agreement with some of the
experimental ﬁndings, such as antigenicity changes at low
pH, membrane-fusion activity of crosslinked mutants,
electron microscopy, etc.
In models 1 and 3, which are energetically less favorable,
extension of the coiled coil and exposure of fusion peptides
occurred with only a partial separation of the globular
domains. This indicates that complete dissociation of the
globular domains is not essential for extension of the coiled
coil and exposure of the fusion peptides. In the simulations
the fusion peptides were displaced only when the helix-to-
loop transition (HA2:105-112), which reverses the direction
of the C-terminal portion of HA2, occurs in the reaction
pathway. In the native state the fusion peptides are hydrogen-
bonded to the above-mentioned helix region. Thus, local
destabilization in this region may trigger the extrusion of the
fusion peptide. The absence of complete dissociation of the
globular domains in Path 1 may be a result of the short time
scale of the simulation. Longer simulations might produce
dissociation of the partially opened globular domains and
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allow the fusion peptides to move closer to the target
membrane.
Our simulations have a number of limitations. First,
sampling of the system was limited to a total of 4.5 ns for
each TMD path (7.5 ns for the second path). This may not
provide enough time for the unrestrained part of the molecule
to ﬁnd an optimal conﬁguration with respect to the restrained
part. Secondly, in this study we considered only three paths
for obtaining the low-pH models. Although reasonable, these
may not correspond to the optimal path. Thirdly, no mem-
branes were present in our study, therefore any protein-
membrane interactions that could be important in the
conformational change have been neglected. Finally, this
study has not addressed the question why low pH triggers the
conformational transition. This could be addressed in the
future by calculations of the pKa of titratable residues in HA.
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